Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3584]

Scientists identify dozens of genes allowing cancer cells to evade the immune system

Scientists identify dozens of genes allowing cancer cells to evade the immune system

Potential cause of immunotherapy-related neurotoxicity

Potential cause of immunotherapy-related neurotoxicity

ESMO 2020: Immunotherapy combination improves outcomes in advanced kidney cancer

ESMO 2020: Immunotherapy combination improves outcomes in advanced kidney cancer

ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers

ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers

ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer

ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer

ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer

ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer

ESMO 2020: First-time data revealed from two studies evaluating pembrolizumab plus lenvatinib in seven different tumour types

ESMO 2020: First-time data revealed from two studies evaluating pembrolizumab plus lenvatinib in seven different...

ESMO 2020: Sacituzumab govitecan-hziy extends survival in phase 3 ASCENT study of metastatic triple-negative breast cancer

ESMO 2020: Sacituzumab govitecan-hziy extends survival in phase 3 ASCENT study of metastatic triple-negative...

ESMO 2020: KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial

ESMO 2020: KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial

ESMO 2020: New first-line treatment option for metastatic kidney cancer, according to results of phase 3 study

ESMO 2020: New first-line treatment option for metastatic kidney cancer, according to results of phase 3 study

More from ecancer